-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
CompilationFan Dongdong
The executives of pharmaceutical companies are usually known for their high incomes.
In the past few weeks, life sciences and biopharmaceutical companies have successively announced year-end financial reports, including the total compensation of the CEO and other members of the executive team in 2020.
The salary of the CEO of the new crown vaccine manufacturer has risen! Pfizer, BioNTech, Johnson & Johnson.
Most of the increase in the amount is in the form of bonuses and stock options.
The salary of some CEOs this year only increased by a few percentage points year-on-year.
If shareholder approval is obtained later this month, Johnson & Johnson CEO Alex Gorsky’s total compensation will be increased to $30 million.
Although Teva, the Israeli-based generic drug giant, is not on the list of the top 20 pharmaceutical companies by market capitalization, its CEO, Kåre Schultz, is expected to significantly increase its annual salary.
The following is based on the data released by the top 20 biopharmaceutical companies ranked by market capitalization, the basic salary table of CEOs prepared:
Reference source: CEO Salaries for the Top 20 Pharma Companies by Market Cap